Changes in Body Adiposity, Dietary Intake, Physical Activity and Quality of Life of Obese Individuals Submitted to Intragastric Balloon Therapy for 6 Months
Obesity is an important risk factor for several chronic diseases and also is associated with worse quality of life. Intragastric balloon (IGB) is an effective method for weight loss. Although changes in lifestyle are critical to weight loss during and after IGB therapy, only a few studies evaluated dietary intake and none evaluated changes in physical activity with a validated questionnaire during the treatment. The aim of this study was to evaluate changes in total and central body adiposity, dietary intake, physical activity, and quality of life of patients with obesity submitted to IGB treatment for 6 months.
Prospective observational study involving 42 patients with obesity using IGB for 6 months. The patients were evaluated, on the day of insertion and withdrawal or adjustment of IGB for total and central body adiposity (anthropometry and bioelectrical impedance), dietary intake, physical activity (Baecke questionnaire), and quality of life (SF-36 questionnaire).
There was a significant decrease in total and central body adiposity. The mean % total weight loss and % excess weight loss were 15.88 ± 1.42 and 56.04 ± 4.90, respectively and waist circumference decreased 13.33 ± 1.39 cm. There was a reduction in energy intake, an increase in physical activity, and an improvement of quality of life during IGB treatment.
The present study suggests that IGB treatment during 6 months in individuals with obesity is effective for decreasing total and central body adiposity being associated with reduction in energy intake, increase in physical activity, and improvement in quality of life.
KeywordsIntragastric balloon Obesity Weight loss Quality of life Dietary intake
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
Informed consent was obtained from all individual participants included in the study.
The study was reviewed and approved by the Committee on Ethics and Research of Pedro Ernesto University Hospital/Rio de Janeiro State University.
All procedures performed in the study were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
- 2.GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017 377(1):13–27.Google Scholar
- 3.Jensen MD, Ryan DH, Apovian CM, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Obesity Society 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol. 2014;63(25 Pt B):2985–3023.CrossRefPubMedGoogle Scholar
- 7.Upadhyay J, Farr O, Perakakis N, et al. Obesity as a disease. Med Clin N Am. 2018;(102):13–33.Google Scholar
- 10.WHO - World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. WHO Techinical Report Series (894).Geneva, 2000.Google Scholar
- 12.Garvey WT, Mechanick JI, Brett EM, et al. American Association Of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity executive Summary Complete Guidelines available at https://www.aace.com/publications/guidelines. Endocr Pract. 2016;22(7):842–84.CrossRefPubMedGoogle Scholar
- 13.Associação Brasileira para o Estudo da Obesidade e da Síndrome Metabólica. Diretrizes brasileiras de obesidade 2016 / ABESO - Associação Brasileira para o Estudo da Obesidade e da Síndrome Metabólica. – 4.ed. - São Paulo, SP. Disponível em: http://www.abeso.org.br/uploads/downloads/92/57fccc403e5da.pdf.
- 16.Ali MR, Moustarah F, Kim JJ. American Society for Metabolic and Bariatric Surgery Clinical Issues Committee. American Society for Metabolic and Bariatric Surgery position statement on intragastric balloon therapy endorsed by the Society of American Gastrointestinal and Endoscopic Surgeons. Surg Obes Relat Dis. 2016;12(3):462–7.CrossRefGoogle Scholar
- 18.Neto MG, Silva LB, Grecco E, de Quadros LG, Teixeira A, Souza T et al. Brazilian Intragastric Balloon Consensus Statement (BIBC): practical guidelines based on experience of over 40,000 cases. Surg Obes Relat Dis. 2017;28. pii: S1550–S7289.
- 22.Karagiozoglou-Lampoudi T, Papakostas P, Penna S, et al. Effective intragastric balloon treatment in obese adolescents. Ann Gastroenterol. 2009;22(1):46–51.Google Scholar
- 35.WHO STEP wise approach to surveillance (STEPS). [homepage na Internet] Geneva: World Health Organization (WHO), 2008. available at: http://www.who.int/chp/steps/manual/en/index.
- 37.Zhou JY, Ge H, Zhu M, et al. Neck circumference as an independent predictive contributor to cardio-metabolic syndrome. Cardiovasc Diabetol. 2013;12(76):2–7.Google Scholar
- 38.Segal KR, Van Loan M, Fitzgerald PI, et al. Lean body mass estimation by bioelectrical impedance analysis: a four-site cross-Validation study. Am J Clin Nutr. l988;47:7–14.Google Scholar
- 39.Gray DS, Bray GA, Gemayel N, et al. Effect of obesity on bioelectrical impedance. Am J Clin Nutr. l989;50:–255, 60.Google Scholar
- 43.Ciconelli RM, Ferraz MB, Santos W, et al. Tradução para a língua portuguesa e validação do questionário genérico de avaliação de qualidade de vida SF-36 (Brasil SF-36). Rev Bras Reumatol. 1999;39(3):143–50.Google Scholar